kaal:position:2026-07-31-1243

Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury. should be assessed against Kaal's source-bound claim that Regulation is mostly reactive and follows business cycles rather than being proactive; data on venture capital investments lets regulators see where innovation trends are heading and what risks they entail before the disruptive innovation actually materializes. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

• regulators with access to venture capital investment data
• innovation still at the investment rather than deployment stage
• External evidence level: metadata only.
• Mapping review tier: mapping review before claim review.
• The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury.

kaal:claim:2808132-043
Wulf A. Kaal, Erik P.M. Vermeulen, How to Regulate Disruptive Innovation - From Facts to Data (2016). SSRN: https://ssrn.com/abstract=2808132
Source PDF sha256: 3515f2317ed9c1d33ae55d70467cdf1f6c4e350065ea6a887d5d7619599ad7d2

Evidence: metadata only
Review tier: mapping review before claim review
Mapping confidence: 0.3361
Mapping ambiguous: true

innovationdynamic-regulationresearch-methodsrisk-and-incentives

Affirmed in historical-backfill:2026-07-31:phase-0005 on 2026-07-31. Review record.

Canonical markdown sha256: f21fc15a210b4c5b7f9fc48164aa18aac03b0867fbca563668d1799effeaa8f5
curl -s https://wulfkaal.github.io/positions/2026-07-31-1243.md | sha256sum